Combining Two Diabetes Drugs Helps Promote Weight Loss and Blood Sugar Control, suggests study Dr. Kamal Kant Kohli2 Sept 2024 7:00 AM ISTNew research finds a combination of drugs improves weight loss, glucose control and insulin resistance better than either drug alone. Using two...
Weekly Semaglutide 2.4 mg Shows Promise in Treating Obesity and Prediabetes: Results from STEP 10 Phase 3 Trial Nidhi Srivastava28 Aug 2024 9:45 PM ISTUK: A study published in The LANCET Diabetes and Endocrinology revealed that Semaglutide 2.4 mg led to significantly greater weight loss and a higher...
Semaglutide has heart benefits that extend to patients with heart failure, reveals Lancet study Dr. Kamal Kant Kohli27 Aug 2024 8:30 AM ISTThe anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events among overweight people who have...
Medical Bulletin 26/ August/ 2024 Dr. Garima Soni26 Aug 2024 3:00 PM ISTHere are the top medical news for the day:High-Risk HPV Affects Male Reproductive Health A new study published in Frontiers in Cellular and Infection...
Weight Loss Drug's Cardiovascular Benefits for Heart Failure Patient: Study Dr. Garima Soni26 Aug 2024 9:15 AM ISTThe new study, published in The Lancet, found that the anti-obesity drug semaglutide might aid in preventing heart attacks and other significant...
Dr. Reddy's Lab gets CDSCO Panel nod to study Semeglutide injection Dr. Divya Colin10 Aug 2024 6:00 PM ISTNew Delhi: In line with the bioequivalence study report of Semaglutide Injection 2mg/1.5ml (1.34mg/ml) and 4mg/3ml (1.34mg/ml) (Synthetic Origin)...
Assessing Semaglutide's Safety Profile Reveals Low Risk of NAION: Study Dr. Garima Soni9 Aug 2024 3:00 AM ISTIndia: Association of semaglutide with the occurrence of nonarteritic anterior ischemic optic neuropathy (NAION) is very low, a current study...
Semaglutide Promotes Weight Loss and Improves HF Outcomes in Patients with Obesity-Related HFpEF: JACC Medha Baranwal8 Aug 2024 10:00 AM ISTUSA: Insights from the STEP-HFpEF program showed the efficacy of semaglutide in reducing N-terminal pro-B-type natriuretic peptide (NT-proBNP) in...
Drugs not yet marketed in India, Submit PSUR Data: CDSCO Panel Tells Novo Nordisk on Semaglutide injection Dr. Divya Colin6 Aug 2024 6:00 PM ISTNew Delhi: Noting that proposed drug products Semaglutide Injection 0.25mg/0.5mg/1mg/1.7mg/2.4mg (Wegovy) and Semaglutide Injection...
FDA Alerts on Overdosing Risks with Compounded Semaglutide Due to Dosing Errors and Variability Medha Baranwal1 Aug 2024 9:30 AM ISTUSA: Patients are experiencing overdoses of compounded semaglutide due to errors in both self-administration and clinician calculations, which may...
Data shows surge in new GLP-1RA prescriptions for obesity without type 2 diabetes, reveals study Dr. Kamal Kant Kohli31 July 2024 8:45 AM ISTA nationwide study found a marked increase in new GLP-1RA prescriptions over the last decade, particularly since 2020. Semaglutide was the most...
Semaglutide promising for smoking cessation among patients of tobacco use disorder, suggests study Dr. Kamal Kant Kohli30 July 2024 7:45 PM ISTNew use of semaglutide was associated with a lower risk for medical care related to tobacco use disorder (TUD) in smokers with type 2 diabetes...
